<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pak J Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Pak J Med Sci</journal-id><journal-title-group><journal-title>Pakistan Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">1682-024X</issn><issn pub-type="epub">1681-715X</issn><publisher><publisher-name>Professional Medical Publications</publisher-name><publisher-loc>Pakistan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29492060</article-id><article-id pub-id-type="pmc">5768826</article-id><article-id pub-id-type="publisher-id">PJMS-33-1366</article-id><article-id pub-id-type="doi">10.12669/pjms.336.12900</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Neutrophil lymphocyte ratio (NLR): A well assessment tool of glycemic control in type 2 diabetic patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hussain</surname><given-names>Mazhar</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Babar</surname><given-names>Muhammad Zafar Majeed</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Akhtar</surname><given-names>Lubna</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hussain</surname><given-names>Muhammad Shahbaz</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Dr. Mazhar Hussain, MBBS, M.Phil. Department of Pharmacology, Sheikh Zayed Medical College &#x00026; Hospital, Rahim Yar Khan, Pakistan</aff><aff id="aff2"><label>2</label>Dr. Muhammad Zafar Majeed Babar, MBBS, FCPS. Department of Medicine, Sheikh Zayed Medical College &#x00026; Hospital, Rahim Yar Khan, Pakistan</aff><aff id="aff3"><label>3</label>Dr. Lubna Akhtar, MBBS, FCPS. Department of Pharmacology, Sheikh Zayed Medical College &#x00026; Hospital, Rahim Yar Khan, Pakistan</aff><aff id="aff4"><label>4</label>Dr. Muhammad Shahbaz Hussain, MBBS, M.Phil. Department of Microbiology, Sheikh Zayed Medical College &#x00026; Hospital, Rahim Yar Khan, Pakistan</aff><author-notes><corresp id="cor1">
Correspondence: Dr. Mazhar Hussain, Associate Professor of Pharmacology, Sheikh Zayed Medical College Rahim Yar Khan, <bold><italic>Postal Address:</italic></bold> House no 214/c Satellite Town, Rahim Yar Khan, Punjab 64200-Pakistan. Email: <email xlink:href="mazharhussain214@gmail.com">mazharhussain214@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2017</year></pub-date><volume>33</volume><issue>6</issue><fpage>1366</fpage><lpage>1370</lpage><history><date date-type="received"><day>10</day><month>4</month><year>2017</year></date><date date-type="rev-recd"><day>24</day><month>8</month><year>2017</year></date><date date-type="accepted"><day>26</day><month>8</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Pakistan Journal of Medical Sciences</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0">http://creativecommons.org/licenses/by/3.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background and Objective:</title><p>Increased neutrophil lymphocyte ratio (NLR) is a marker as well as predictor of various cardiac and non cardiac disorders. Our aim was to assess the relationship between NLR and different level of glycemic control in type 2 diabetic patients.</p></sec><sec id="st2"><title>Methods:</title><p>An observational study was conducted at diabetic clinic of Sheikh Zayed Medical College/Hospital, Rahim Yar Khan from September 2016 to February 2017 in which 330 type 2 diabetic patients were randomly divided in to three groups based upon diabetes control according to ADA criteria. Patients in group A with HbA1c &#x02264; 7% (excellent control), group B HbA1c 7.0-9.0 % (poor control) and group C HbA1c &#x02265; 9 %(worst control). Patients were assessed in terms of complete blood count and C - reactive protein.</p></sec><sec id="st3"><title>Results:</title><p>As compared to excellent control (Group A) patients with worst control (Group C)showed a high leukocyte count (p.001), high neutrophil count (P.003) and lower lymphocyte count (P 0.44) while patients in poor control (Group B)did not differ significantly. Similarly value of NLR was also significantly higher in worst control (Group C) as compared to poor control(Group B) and excellent control (Group A) diabetes (4.3&#x000b1;2.8, 2.7&#x000b1;1.0 and2.0&#x000b1;0.5(p.001). NLR were found independent predictor of worst diabetes control (OR: 1.809, 95% CI: 1.459-2.401) along with fasting blood sugar (OR: 0.938, 95% CI: 0.995-0.982) and CRP (OR: 1.020, 95% CI: 1.003-1.028).</p></sec><sec id="st4"><title>Conclusion:</title><p>Increased NLR level is associated with elevated HbA1c and poor glycemic control in patients of type 2 diabetes mellitus. It can be used as a disease monitoring tool during the follow up of diabetic patients.</p></sec></abstract><kwd-group><kwd>NLR</kwd><kwd>Type 2 diabetes</kwd><kwd>CRP</kwd><kwd>HbA1c</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Diabetes mellitus a chronic preventable metabolic disorder and is considered to be one of the silent killer all across the globe because most of the patient remain asymptomatic for years unless they develop complications. The burden of diabetes is on the rise in middle and lower income countries due to strong influence of urbanization, sedentary life style, nutritional and epidemiological transition.<xref rid="ref1" ref-type="bibr">1</xref> It is estimated that the rise of type 2 diabetes in South Asian countries is more than 150% between 2000 and 2035. Therefore drastic steps are required through various health awareness programs in order to control the escalating trends of diabetes in these countries to reduce disease burden.<xref rid="ref2" ref-type="bibr">2</xref></p><p>The increased number of circulating leukocytes not only reflects a presence of acute infection in the body but they have also a dominant inflammatory role in the pathogenesis of different phases of atherosclerosis from its start to advancement and ultimately complications in the form of eventual rupture of atherosclerosis plaque that leads to various cardiovascular disorders. Studies have shown that increased leukocyte counts are reliable markers of systemic inflammation and have diagnostic as well as prognostic value in patients of angina, myocardial infarction, stroke, peripheral vascular disease and micro and macro vascular complication associated with diabetes.<xref rid="ref3" ref-type="bibr">3</xref>,<xref rid="ref4" ref-type="bibr">4</xref></p><p>Now a day&#x02019;s there is more concern about neutrophil lymphocyte ratio NLR, a potential marker to determine inflammation in various cardiac and non-cardiac disorders because it has a superior predictive, diagnostic and discriminative ability than total WBC count. Moreover predictive value of NLR is comparable to various other inflammatory markers such as C &#x02013; reactive protein (CRP), tumor necrosis factor (TNF-&#x003b1;) and interleukin (IL-6) in the detection of subclinical inflammation and endothelial dysfunction in various clinical studies.<xref rid="ref5" ref-type="bibr">5</xref>,<xref rid="ref6" ref-type="bibr">6</xref> NLR, a traditional marker has various advantages over other inflammatory markers because of its wide availability, low cost, reliability, easy lab detection. Moreover NLR can be used as population screening, disease and drug monitoring tool on large scale basis. Even patients with increase NLR but normal TLC count could have increased risk of atherosclerosis related diseases.<xref rid="ref7" ref-type="bibr">7</xref>-<xref rid="ref9" ref-type="bibr">9</xref></p><p>HbA1c is a widely available test which is usually advised by most clinicians to measures the long term glycemic control in diabetic patients over the period of previous 2-3 months.HbA1c also tells about the severity of hyperglycemia and considered to be a biomarker of risk factors for diabetes related micro and macro-vascular complications.<xref rid="ref10" ref-type="bibr">10</xref> However HbA1c usually do not predict ongoing inflammation and diabetes associated complications which are more precisely done by NLR. The present study was designed to assess relationship between NLR and glycemic control which was done by comparing NLR with HbA1c in terms of excellent, poor and worst diabetes control and compare them with CRP which is the most studied inflammatory markers.</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><p>This observational study was carried out at diabetic clinic of Sheikh Zayed Medical College/Hospital, Rahim Yar Khan from November 2016 to February 2017. All patients gave a written informed consent and study was approved by ethical committee. Initially 550 type 2 diabetic patients who came in diabetic clinic for regular follow up were recruited. On the basis of inclusion criteria, a total of 330 patients of both sexes were enrolled in the study. They were randomly divided in to three groups each contained 110 patients based on the severity of diabetes control according to ADA criteria. Patients in group A with HbA1c &#x02264; 7% termed as (excellent control), group B HbA1c 7-9% (poor control) and patients group C HbA1c &#x02265; 9% (worst control) respectively. A detailed history and general physical examination were undertaken to rule out any causes which affects inflammation such as vitals and any localizing signs. The exclusion criteria were any acute or chronic infections and inflammatory conditions for last two weeks. Patients with chronic heart failure, bleeding disorders, hematological disorders, dyslipidemia, hypertension, autoimmune diseases, cancers, severe liver and kidney disorders were excluded from the study. In addition detailed history was taken about smoking, alcohol use and drugs which effect inflammation like antidyslipidemic agents, non steroidal anti inflammatory drugs (NSAIDS), opiods analog, hormonal contraceptives, steroids, immuno-suppressive and immune- modulators drugs.</p><p>Blood sample was collected from the median cubital vein after an overnight fasting of 12 hours. Total leukocyte counts (TLC) were measured by automated hematology analyzer. Neutrophil lymphocyte ratios (NLR) were estimated by dividing the absolute neutrophil ratio to absolute lymphocyte ratio. HbA1c level was measured by high performance liquid chromatography using automated ion exchange method while CRP level was measured by spectro photometry method.</p><sec id="sec2-1"><title>Data Analysis</title><p>Statistical package for social sciences (SPSS-16) were used for data analysis. Data were presented as mean &#x000b1; standard deviation for continuous variables and percentages for categorical variables. The independent sample t test or Mann- Whitney U test was used for the continuous variable while chi-square for the categorical variables. ANOVA or Kruskal-Wallis test were used to compare the three groups. Multivariate logistic regression analysis was used with significant independent variables in association with worst diabetes control. All significant variables in univariate analysis were included in the logistic regression model shown as odds ratio (OR) and 95% confidence interval (CIs). A 2-tailed p &#x02264; was deemed to be statistically significant.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>Demographic characteristics and hematological parameters at baseline of excellent control (Group A), poor control (Group B) and worst control (Group C) are shown in <xref ref-type="table" rid="T1">Table-I</xref>. There were no significant statistical differences in terms of age, sex, family history and duration of diabetes in three groups. However serum glucose (P=0.004) and BMI (P=0.002) were significantly higher in worst control (Group C). Hemoglobin and platelets count were similar in all study groups. As compared to excellent control (Group A), Patients with worst control (Group C) showed a high leukocyte count (p=0.001), high neutrophil count (P= 0.003) and lower lymphocyte count(P= 0.44) while patients with poor control (Group B) did not differ. The value of NLR was also significantly higher in worst control(Group C) as compared to poor control (Group B)and excellent control(Group A)(4.3&#x000b1;2.8,2.7&#x000b1;1.0 and2.0&#x000b1;0.5 respectively p.001) <xref ref-type="table" rid="T1">Table-I</xref>.</p><table-wrap id="T1" position="float"><label>Table-I</label><caption><p>Baseline characteristics of three groups.<sup><xref ref-type="table-fn" rid="t1f1">a</xref></sup></p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"><italic>Parameters</italic></th><th align="center" rowspan="1" colspan="1"><italic>Group A n=110 (HbAIc &#x0003c;7%) Excellent control</italic></th><th align="center" rowspan="1" colspan="1"><italic>Group B n=110 (HbAIc 7-9%) Poor control</italic></th><th align="center" rowspan="1" colspan="1"><italic>Group C n=110 (HbAIc &#x0003e;9%) Worst control</italic></th><th align="center" rowspan="1" colspan="1"><italic>P Value<sup><xref ref-type="table-fn" rid="t1f2">b</xref></sup></italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age(years)</td><td align="center" rowspan="1" colspan="1">62.6&#x000b1;13.0</td><td align="center" rowspan="1" colspan="1">64.6&#x000b1;15.9</td><td align="center" rowspan="1" colspan="1">60.4&#x000b1;12.7</td><td align="center" rowspan="1" colspan="1">0.226</td></tr><tr><td align="left" rowspan="1" colspan="1">Male (n-%)</td><td align="center" rowspan="1" colspan="1">52(74)</td><td align="center" rowspan="1" colspan="1">48(68)</td><td align="center" rowspan="1" colspan="1">54(77)</td><td align="center" rowspan="1" colspan="1">0.375</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">26.5&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">27.2&#x000b1;3.2</td><td align="center" rowspan="1" colspan="1">29.2&#x000b1;3.8</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes&#x0003e;10years (n-%)</td><td align="center" rowspan="1" colspan="1">14(20)</td><td align="center" rowspan="1" colspan="1">17(24)</td><td align="center" rowspan="1" colspan="1">19(27)</td><td align="center" rowspan="1" colspan="1">0.502</td></tr><tr><td align="left" rowspan="1" colspan="1">Family history of CAD (n-%)</td><td align="center" rowspan="1" colspan="1">15(21)</td><td align="center" rowspan="1" colspan="1">12(17)</td><td align="center" rowspan="1" colspan="1">16(23)</td><td align="center" rowspan="1" colspan="1">0.404</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose(mg/dl)</td><td align="center" rowspan="1" colspan="1">106&#x000b1;24.2</td><td align="center" rowspan="1" colspan="1">124&#x000b1;45.8</td><td align="center" rowspan="1" colspan="1">152.8&#x000b1;65.4</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td align="left" rowspan="1" colspan="1">Hemoglobin g/dl</td><td align="center" rowspan="1" colspan="1">12.8&#x000b1;1.84</td><td align="center" rowspan="1" colspan="1">12.7&#x000b1;2.23</td><td align="center" rowspan="1" colspan="1">13.1&#x000b1;1.5</td><td align="center" rowspan="1" colspan="1">0.392</td></tr><tr><td align="left" rowspan="1" colspan="1">Platelets count&#x000d7;<sub>10<sup>9</sup>/L</sub></td><td align="center" rowspan="1" colspan="1">245&#x000b1;85</td><td align="center" rowspan="1" colspan="1">254&#x000b1;76</td><td align="center" rowspan="1" colspan="1">249&#x000b1;80</td><td align="center" rowspan="1" colspan="1">0.390</td></tr><tr><td align="left" rowspan="1" colspan="1">WBC count &#x000d7;<sub>10<sup>9</sup>/L</sub></td><td align="center" rowspan="1" colspan="1">7.4&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">8.6&#x000b1;3.6</td><td align="center" rowspan="1" colspan="1">9.8&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutrophil count&#x000d7;<sub>10<sup>9</sup>/L</sub></td><td align="center" rowspan="1" colspan="1">4.6&#x000b1;2.4</td><td align="center" rowspan="1" colspan="1">5.6&#x000b1;3.2</td><td align="center" rowspan="1" colspan="1">7.4&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocyte count&#x000d7;<sub>10<sup>9</sup>/L</sub></td><td align="center" rowspan="1" colspan="1">2.3&#x000b1;0.8</td><td align="center" rowspan="1" colspan="1">2.3&#x000b1;0.7</td><td align="center" rowspan="1" colspan="1">2.0&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">0.44</td></tr><tr><td align="left" rowspan="1" colspan="1">NLR</td><td align="center" rowspan="1" colspan="1">2.0&#x000b1;0.5</td><td align="center" rowspan="1" colspan="1">2.7&#x000b1;1.0</td><td align="center" rowspan="1" colspan="1">4.3&#x000b1;2.8</td><td align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">CRP</td><td align="center" rowspan="1" colspan="1">0.8&#x000b1;0.92</td><td align="center" rowspan="1" colspan="1">2.62&#x000b1;0.42</td><td align="center" rowspan="1" colspan="1">4.43&#x000b1;0.54</td><td align="center" rowspan="1" colspan="1">0.003</td></tr></tbody></table><table-wrap-foot><fn><p>BMI, body mass index; NLR, neutrophil to lymphocyte ratio; CRP, C-reactive protein;</p><p>SD, standard deviation; ANOVA, analysis of variance</p></fn><fn id="t1f1"><label>a</label><p>Values are mean&#x000b1; SD or n(%)</p></fn><fn id="t1f2"><label>b</label><p>ANOVA, Chi-square test or Kruskal-Wallis</p></fn></table-wrap-foot></table-wrap><p>A multivariate analysis showed that high level of NLR was independent predictor of worst diabetes control (Group C)(OR: 1.809, 95% CI: 1.459-2.401) along with fasting blood sugar (OR: 0.938, 95% CI: 0.995-0.982) and CRP (OR:1.020, 95% CI: 1.003-1.028). <xref ref-type="table" rid="T2">Table-II</xref></p><table-wrap id="T2" position="float"><label>Table-II</label><caption><p>Multivariate logistic regression analysis with significant variable in association with worst diabetic control.</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"><italic>Odds Ratio (%95 confidence interval)</italic></th><th align="center" rowspan="1" colspan="1"><italic>P value</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">NLR</td><td align="center" rowspan="1" colspan="1">1.809(1.459-2.401)</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose mg/dl</td><td align="center" rowspan="1" colspan="1">0.938(0.995-0.982)</td><td align="center" rowspan="1" colspan="1">.021</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="center" rowspan="1" colspan="1">1.905(0.453-9.644)</td><td align="center" rowspan="1" colspan="1">.589</td></tr><tr><td align="left" rowspan="1" colspan="1">CRP</td><td align="center" rowspan="1" colspan="1">1.020(1.003-1.028)</td><td align="center" rowspan="1" colspan="1">.001</td></tr></tbody></table><table-wrap-foot><fn><p>CI, NLR, neutrophil to lymphocyte ratio; BMI, body mass index; C-reactive protein</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>In this study we noticed a strong correlation between NLR and HbA1c. This is perhaps the first observational study to see the impact of NLR on different level of glycemic control on the basis of HbA1c values in type 2 diabetic patients and compare them with CRP. NLR is easily calculated from routine blood test by dividing the absolute neutrophil ratio to absolute lymphocyte ratio. It is more reliable than complete blood count in detecting subclinical inflammation in cardiac and non cardiac disorders. Studies have shown that NLR is not an inflammatory marker but it has strong diagnostic as well as prognostic potential for atherosclerosis related vascular diseases in which diabetes mellitus is one of them.<xref rid="ref11" ref-type="bibr">11</xref>,<xref rid="ref12" ref-type="bibr">12</xref></p><p>A dominant role of NLR was seen in various studies conducted on diabetic patients. Shiny et al<xref rid="ref13" ref-type="bibr">13</xref> and Lou et al<xref rid="ref14" ref-type="bibr">14</xref> revealed that increased NLR has strong association with glucose intolerance and insulin resistance in type 2 diabetic patients. Regarding diabetes related micro vascular complications studies showed that NLR has a reliable predictive marker of early stage diabetic nephropathy<xref rid="ref15" ref-type="bibr">15</xref>, retinopathy<xref rid="ref16" ref-type="bibr">16</xref> and diabetic foot ulcer.<xref rid="ref17" ref-type="bibr">17</xref> Moreover increased NLR is predictor of major cardiovascular events in both acute coronary syndrome and coronary artery disease patients and is also associated with increased carotid artery intima-media thickness in type 2 diabetic patients.<xref rid="ref18" ref-type="bibr">18</xref>,<xref rid="ref19" ref-type="bibr">19</xref></p><p>In spite of extensive clinical studies of NLR in diabetic patients. Limited Data is available to determine the effect of NLR on glycemic control. Selfil et al<xref rid="ref20" ref-type="bibr">20</xref> revealed that increase NLR may be associated with elevated HbA1c in type 2 diabetic patients. Shiny et al<xref rid="ref13" ref-type="bibr">13</xref> compared the NLR value with normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and type 2 diabetes mellitus (DM) and found a significant correlation with IGT and DM. Oh et al<xref rid="ref21" ref-type="bibr">21</xref> and Demirtas et al<xref rid="ref22" ref-type="bibr">22</xref> demonstrated association between glycemic control and hematological indices in type 2 diabetic patients and concluded that NLR can be used as a marker of diabetic regulations and complications during the follow up period of diabetic patients.</p><p>The present study showed that hyperglycemia is strongly related to increase NLR (i.e. decrease lymphocyte count and increase lymphocyte count). Even in our study a strong positive correlation was found between NLR and CRP in patients with worst diabetes control. Elevated CRP relation with white blood cells for glycemic control has been investigated in number of clinical studies.<xref rid="ref23" ref-type="bibr">23</xref>-<xref rid="ref24" ref-type="bibr">24</xref> Our study showed that NLR not only assess different level of glycemic control but its high level may also predict that patient with worst control diabetes is likely to develop complications in future. So NLR is not an inflammatory marker only but also a direct cause of cardiovascular disease in diabetic patients like CRP.</p><sec id="sec2-2"><title>Limitation of study</title><p>The main limitation of our study was that we cannot correlate different antidiabetic agents used by patients with NLR as some antidiabetic drugs have also anti-inflammatory activity in addition to glycemic control.</p></sec></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>NLR values are assessment tool of different level of glycemic control in type 2 diabetic patients. Its high value is a predictor of worst diabetic control. So it can be used as a disease monitoring tool during the follow up of diabetic patients.</p></sec><sec id="sec1-6"><title>RECOMMENDATION</title><p>NLR is a routinely performed test and is cost effective than HbA1c. It should be recommended in diabetic patients in routine clinical setting not for glycemic control but also for prediction of diabetes related complications in future so that effective measures should be taken in order to prevent these complications.</p></sec></body><back><ack><title>ACKNOWLEDGEMENT</title><p>The authors are thankful to department of pathology of Sheikh Zayed Medical College//hospital, Rahim Yar Khan.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold><italic>Declaration of interest:</italic></bold> None.</p></fn><fn fn-type="financial-disclosure"><p><bold><italic>Financial Support:</italic></bold> None</p></fn></fn-group><sec id="sec2-3"><title>Authors&#x02019; Contribution</title><p><bold><italic>Dr. Mazhar Hussain &#x00026; Dr. Lubna Akhtar</italic></bold> conceived the idea, designed the study, collected the clinical data, manuscript review and statistical analysis.</p><p><bold><italic>Dr. Muhammad Zafar Majeed Babar &#x00026; Dr. Muhammad Shahbaz Hussain</italic></bold> searched the literature, data analysis, preparing, editing and drafting the manuscript.</p><p>All members hereby agree to take responsibility of the work and confirm that all questions related to the accuracy and integrity of the research has been properly and thoroughly resolved.</p></sec><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>FB</given-names></name></person-group><article-title>Globalization of diabetes</article-title><source>Diabetes Care</source><year>2011</year><volume>34</volume><issue>6</issue><fpage>1249</fpage><lpage>1257</lpage><pub-id pub-id-type="pmid">21617109</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nanditha</surname><given-names>A</given-names></name><name><surname>Ma</surname><given-names>RC</given-names></name><name><surname>Ramachandran</surname><given-names>A</given-names></name><name><surname>Snehalatha</surname><given-names>C</given-names></name><name><surname>Chan</surname><given-names>JC</given-names></name><name><surname>Chia</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Diabetes in Asia and the Pacific:implications for the global epidemic</article-title><source>Diabetes Care</source><year>2016</year><volume>39</volume><issue>3</issue><fpage>472</fpage><lpage>485</lpage><pub-id pub-id-type="pmid">26908931</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madjid</surname><given-names>M</given-names></name><name><surname>Fatemi</surname><given-names>O</given-names></name></person-group><article-title>Components of the complete blood count as risk predictor for coronary heart disease:a review</article-title><source>Tex Heart I J</source><year>2013</year><volume>40</volume><issue>1</issue><fpage>17</fpage><lpage>29</lpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>PC</given-names></name><name><surname>Chan</surname><given-names>WB</given-names></name><name><surname>Lee</surname><given-names>KF</given-names></name><name><surname>Lo</surname><given-names>MK</given-names></name><name><surname>So</surname><given-names>WY</given-names></name><name><surname>Chan</surname><given-names>NN</given-names></name></person-group><article-title>White blood cells count is associated with macro and microvascular inflammation complications in Chinese patients with type 2 diabetes</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><fpage>216</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">14693992</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozturk</surname><given-names>C</given-names></name><name><surname>Balta</surname><given-names>S</given-names></name><name><surname>Balta</surname><given-names>I</given-names></name><name><surname>Demirkol</surname><given-names>S</given-names></name><name><surname>Celik</surname><given-names>T</given-names></name><name><surname>Turker</surname><given-names>T</given-names></name><etal/></person-group><article-title>Neutrophil lymphocyte ratio and carotid intima media thickness in patients with behcet disease without cardiovascular involvement</article-title><source>Angiology</source><year>2015</year><volume>66</volume><issue>3</issue><fpage>291</fpage><lpage>296</lpage><comment>doi:10.1177/0003319714527638</comment><pub-id pub-id-type="pmid">24671132</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turkmen</surname><given-names>K</given-names></name><name><surname>Guney</surname><given-names>I</given-names></name><name><surname>Yerlikaya</surname><given-names>EH</given-names></name><name><surname>Tonbul</surname><given-names>HZ</given-names></name></person-group><article-title>The relationship between neutrophil to lymphocyte ratio and inflammation in end stage renal disease patients</article-title><source>Ren Fail</source><year>2012</year><volume>32</volume><issue>2</issue><fpage>155</fpage><lpage>159</lpage><comment>doi:10.3109/0886022X.2011.641514</comment></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balta</surname><given-names>S</given-names></name><name><surname>Celik</surname><given-names>T</given-names></name><name><surname>Mikhailidis</surname><given-names>DP</given-names></name><name><surname>Ozturk</surname><given-names>C</given-names></name><name><surname>Demirkol</surname><given-names>S</given-names></name><name><surname>Aparci</surname><given-names>M</given-names></name><etal/></person-group><article-title>The relationship between atherosclerosis and the neutrophil lymphocyte ratio</article-title><source>Clin Appl Thromb Hemost</source><year>2016</year><volume>22</volume><issue>5</issue><fpage>405</fpage><lpage>411</lpage><comment>doi:10.1177/1076029615569568</comment><pub-id pub-id-type="pmid">25667237</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imtiaz</surname><given-names>F</given-names></name><name><surname>Shafique</surname><given-names>K</given-names></name><name><surname>Mirza</surname><given-names>SS</given-names></name><name><surname>Ayoob</surname><given-names>Z</given-names></name><name><surname>Vart</surname><given-names>P</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name></person-group><article-title>Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic disease in Asian population</article-title><source>International Arch Med</source><year>2012</year><volume>5</volume><fpage>2</fpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balta</surname><given-names>S</given-names></name><name><surname>Kurtoglu</surname><given-names>E</given-names></name><name><surname>Kucuk</surname><given-names>U</given-names></name><name><surname>Demirkol</surname><given-names>S</given-names></name><name><surname>Ozturk</surname><given-names>C</given-names></name></person-group><article-title>Neutrophil lymphocyte ratio as an important assessment tool</article-title><source>Expert Rev Cardiovasc Ther</source><year>2014</year><volume>12</volume><issue>5</issue><fpage>537</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">24745892</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>TJ</given-names></name><name><surname>Basu</surname><given-names>A</given-names></name></person-group><article-title>Biomarkers in diabetes:hemoglobin A1c, vascular and tissue markers</article-title><source>Translational Res</source><year>2012</year><volume>159</volume><issue>4</issue><fpage>303</fpage><lpage>312</lpage><comment>doi:10.1016/j.trsl.2012.01.009</comment></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horne</surname><given-names>BD</given-names></name><name><surname>Anderson</surname><given-names>JL</given-names></name><name><surname>John</surname><given-names>JM</given-names></name><name><surname>Weaver</surname><given-names>A</given-names></name><name><surname>Bair</surname><given-names>TL</given-names></name><name><surname>Jensen</surname><given-names>KR</given-names></name><etal/></person-group><article-title>Which white blood cell subtypes predict increased cardiovascular risk?</article-title><source>J Am Coll Cardiol</source><year>2005</year><volume>45</volume><issue>10</issue><fpage>1638</fpage><lpage>1643</lpage><pub-id pub-id-type="pmid">15893180</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>T</given-names></name><name><surname>Teli</surname><given-names>S</given-names></name><name><surname>Rijal</surname><given-names>J</given-names></name><name><surname>Bhat</surname><given-names>H</given-names></name><name><surname>Raza</surname><given-names>M</given-names></name><name><surname>Khoueiry</surname><given-names>G</given-names></name><etal/></person-group><article-title>Neutrophil to lymphocyte ratio and cardiovascular diseases:a review</article-title><source>Expert Rev Cardiovasc Ther</source><year>2013</year><volume>11</volume><issue>1</issue><fpage>55</fpage><lpage>59</lpage><comment>doi:10.1586/erc.12.159</comment><pub-id pub-id-type="pmid">23259445</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiny</surname><given-names>A</given-names></name><name><surname>Bibin</surname><given-names>YS</given-names></name><name><surname>Shanthirani</surname><given-names>CS</given-names></name><name><surname>Regin</surname><given-names>BS</given-names></name><name><surname>Anjana</surname><given-names>RM</given-names></name><name><surname>Balasubramanyam</surname><given-names>M</given-names></name><etal/></person-group><article-title>Association of neutrophil lymphocyte ratio with glucose intolerance:an indicator of systemic inflammation in patients with type 2 diabetes</article-title><source>Diabetes Technol Ther</source><year>2014</year><volume>16</volume><issue>8</issue><fpage>524</fpage><lpage>530</lpage><pub-id pub-id-type="pmid">24455985</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lou</surname><given-names>M</given-names></name><name><surname>Luo</surname><given-names>P</given-names></name><name><surname>Tang</surname><given-names>R</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Relationship between neutrophil lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients</article-title><source>BMC Endocr Disord</source><year>2015</year><volume>15</volume><issue>1</issue><fpage>9</fpage><pub-id pub-id-type="pmid">25887236</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Haung</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Zeng</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Neutrophil -lymphocyte ratio a reliable predictive marker of early stage diabetic nephropathy</article-title><source>Clin Endocrinol</source><year>2015</year><volume>82</volume><issue>2</issue><fpage>229</fpage><lpage>233</lpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>RT</given-names></name><name><surname>Zhang</surname><given-names>JR</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>KJ</given-names></name></person-group><article-title>Neutrophil lymphocyte ratio is associated with arterial stiffness in diabetic retinopathy in type 2 diabetes</article-title><source>J Diabetes Complications</source><year>2015</year><volume>29</volume><issue>2</issue><fpage>245</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">25483847</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahraman</surname><given-names>C</given-names></name><name><surname>Yumun</surname><given-names>G</given-names></name><name><surname>Kahraman</surname><given-names>NK</given-names></name><name><surname>Namdar</surname><given-names>ND</given-names></name><name><surname>Cosgun</surname><given-names>S</given-names></name></person-group><article-title>Neutrophil lymphocyte ratio in diabetes mellitus patients with and without diabetic foot ulcer</article-title><source>Eur J Med Sci</source><year>2014</year><volume>1</volume><fpage>8</fpage><lpage>13</lpage></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azab</surname><given-names>B</given-names></name><name><surname>Chainani</surname><given-names>V</given-names></name><name><surname>Shah</surname><given-names>N</given-names></name><name><surname>McGinn</surname><given-names>JT</given-names></name></person-group><article-title>Neutrophil lymphocyte ratio as a predictor of major cardiovascular events among diabetic population:a 4 years follow up study</article-title><source>Angiology</source><year>2013</year><volume>64</volume><issue>6</issue><fpage>456</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">22904109</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name></person-group><article-title>High neutrophil to lymphocyte ratio is associated with increased carotid artery intima-media thickness in type 2 diabetes</article-title><source>J Diabetes Invest</source><year>2017</year><volume>8</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selfil</surname><given-names>F</given-names></name><name><surname>Ulutas</surname><given-names>KT</given-names></name><name><surname>Dokuyucu</surname><given-names>R</given-names></name><name><surname>Sumbul</surname><given-names>AT</given-names></name><name><surname>Yengil</surname><given-names>E</given-names></name><name><surname>Yagiz</surname><given-names>AE</given-names></name><etal/></person-group><article-title>Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus</article-title><source>J Int Med Res</source><year>2014</year><volume>42</volume><issue>2</issue><fpage>581</fpage><lpage>588</lpage><pub-id pub-id-type="pmid">24567354</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>Y</given-names></name><name><surname>Kwon</surname><given-names>GC</given-names></name><name><surname>Koo</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name></person-group><article-title>Association between glycemic control and hematolical indices in type 2 diabetic patients</article-title><source>Laboratory Medicine Online</source><year>2016</year><volume>6</volume><issue>3</issue><fpage>134</fpage><lpage>139</lpage></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demirtas</surname><given-names>L</given-names></name><name><surname>Degirmenci</surname><given-names>H</given-names></name><name><surname>Akbas</surname><given-names>EM</given-names></name><name><surname>Ozcicek</surname><given-names>A</given-names></name><name><surname>Timuroglu</surname><given-names>A</given-names></name><name><surname>Gurel</surname><given-names>A</given-names></name><etal/></person-group><article-title>Association of hematological indices with diabetes, impaired glucose regulation and microvascular complications of diabetes</article-title><source>Int J Clin Exp Med</source><year>2015</year><volume>8</volume><issue>7</issue><fpage>11420</fpage><lpage>11427</lpage><pub-id pub-id-type="pmid">26379958</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Bi</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>M</given-names></name><name><surname>Ning</surname><given-names>M</given-names></name></person-group><article-title>Relationship between c-reactive protein, white blood cell count and insulin resistance in Chinese populations</article-title><source>Endocrine</source><year>2011</year><volume>39</volume><issue>2</issue><fpage>175</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">21076976</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oda</surname><given-names>E</given-names></name></person-group><article-title>High sensitivity C-reactive protein and white blood cells counts equally predict development of metabolic syndrome in a Japanese health screening population</article-title><source>Acta Diabetologica</source><year>2013</year><volume>50</volume><issue>4</issue><fpage>633</fpage><lpage>638</lpage><pub-id pub-id-type="pmid">23619894</pub-id></element-citation></ref></ref-list></back></article>